Cardiovascular Autonomic Neuropathy and Distal Symmetric Sensorimotor Polyneuropathy: These Two Diabetic Microvascular Complications do not Invariably Co-Exist

Current Vascular Pharmacology
Kalliopi PafiliN Papanas

Abstract

Cardiovascular autonomic neuropathy (CAN) and distal symmetrical sensorimotor polyneuropathy (DSPN) are serious microvascular complications of diabetes mellitus (DM). Their simultaneous development remains disputable. The aim of the present study was to examine the correlation between CAN and the presence/severity of DSPN in DM. Subjects with type 1 (group A: n=51; mean age 40.4 years) and type 2 DM (group B: n=153; mean age 64.6 years) were studied. Evaluation of DSPN was based on neuropathy disability score. Assessment of CAN was based on the battery of 4 standardized cardiovascular autonomic function tests. In group A, patients with moderate/severe DSPN exhibited a 12-fold higher likelihood of CAN in univariate analysis (p=0.035). However, significance was lost after adjustment for gender, age, DM duration, and haemoglobin A1c. In group A, likelihood for CAN did not correlate with the presence of mild DSPN in univariate and multivariate analysis. In group B, likelihood of CAN was similar in patients with mild and in those with moderate/severe DSPN compared with patients without DSPN in univariate and multivariate analysis. In between group comparison CAN was similarly distributed in the 2 groups (p for interaction=0.367), in...Continue Reading

References

Jul 1, 1992·Journal of Diabetes and Its Complications·A PiaggesiR Navalesi
Apr 12, 1990·The New England Journal of Medicine·W R KennedyJ S Najarian
Oct 2, 1982·British Medical Journal·D J Ewing, B F Clarke
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
May 1, 1997·Journal of Diabetes and Its Complications·P ValensiJ R Attali
Jan 12, 1999·Diabetes Research and Clinical Practice·I LluchJ F Ascaso
Feb 15, 2001·European Journal of Internal Medicine·N TentolourisN Katsilambros
Nov 8, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·P KemplerUNKNOWN EURODIAB IDDM Complications Study Group
Nov 25, 2004·Diabetes Care·Phillip A LowPeter J Dyck
Dec 21, 2004·Journal of the American College of Cardiology·Rodica Pop-BusuiMartin J Stevens
Jul 20, 2005·Current Vascular Pharmacology·Irina G Obrosova, Ulrich A Julius
Jan 24, 2007·Circulation·Aaron I Vinik, Dan Ziegler
Oct 19, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·S LiatisN Katsilambros
Jul 10, 2009·Diabetes Care·Jackie ElliottUNKNOWN EURODIAB Prospective Complications Study Group
Jul 1, 2010·Diabetes Care·Aaron I VinikDan Ziegler
Aug 17, 2010·Journal of Diabetes and Its Complications·Christina VoulgariNicholas Tentolouris
Jun 23, 2011·Diabetes/metabolism Research and Reviews·Vincenza SpalloneUNKNOWN Toronto Consensus Panel on Diabetic Neuropathy
Aug 29, 2012·Diabetic Medicine : a Journal of the British Diabetic Association·N PapanasP Kempler
Jun 19, 2013·Artificial Intelligence in Medicine·Andrew StranieriHerbert F Jelinek
Jan 24, 2014·BioMed Research International·Anca MoţăţăianuZoltán Bajkó
Feb 26, 2014·World Journal of Diabetes·Gerasimos DimitropoulosMartin J Stevens
Dec 19, 2014·Frontiers in Endocrinology·Alberto VerrottiFrancesco Chiarelli
Jan 27, 2015·Journal of Diabetes Investigation·Heung Yong Jin, Tae Sun Park
Dec 18, 2015·The Review of Diabetic Studies : RDS·Nikolaos Papanas, Dan Ziegler
Mar 30, 2016·The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons·Dane K WukichNatalie C Suder
Apr 12, 2016·JAMA Neurology·John T Kissel, A Gordon Smith

❮ Previous
Next ❯

Citations

Mar 17, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Kalliopi PafiliNikolaos Papanas
Aug 20, 2021·Metabolism: Clinical and Experimental·Simona Cernea, Itamar Raz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.